Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT03345069 · ClinicalTrials.gov registry record

Cincinnati Infant Neurodevelopment Early Prediction Study (CINEPS)

A clinical trial of Premature Infant, sponsored by Children's Hospital Medical Center, Cincinnati.

Active
Registry status
393
Enrollment target
1
Study location

NCT03345069 is a study of Premature Infant that is active but no longer recruiting, run by Children's Hospital Medical Center, Cincinnati. The registered enrollment target is 393 participants, above the 246-participant average among 9 other Premature Infant trials with a reported enrollment target (60% higher). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT03345069, a study of Premature Infant, is active but no longer recruiting, sponsored by Children's Hospital Medical Center, Cincinnati.

ACTIVE NOT RECRUITING
Registry status
393 participants
Enrollment target
1
Study location

Study Summary

The Early Prediction Study is a longitudinal population-based cohort study for very preterm infants ≤32 weeks gestational age. Preterm infants recruited from three greater Cincinnati and two Dayton area neonatal intensive care units (NICUs) will undergo advanced MRIs at 41 weeks postmenstrual age and neurodevelopmental testing at the corrected ages of two and three years correct age. The goal of the Early Prediction Study is to accurately predict motor, cognitive, and behavioral deficits in individual very preterm infants using neuroimaging technologies and established epidemiologic approaches.

Conditions Studied

Study Locations (1)

Ohio

  • Cincinnati Children's Hospital Medical Center - Cincinnati

Trial Details

FieldValue
Enrollment Target 393 participants
Start Date 2016-09-16
Est. Completion 2027-11

What the Registry Record Tells You About NCT03345069

The ClinicalTrials.gov registry entry for NCT03345069 describes a study currently listed as active not recruiting, categorized as an unspecified phase. The registered enrollment target is 393 participants, a figure that helps gauge the scale of data the investigators plan to collect, above the 246-participant average among 9 other Premature Infant trials with a reported enrollment target (60% higher). The listed sponsor is Children's Hospital Medical Center, Cincinnati, which has 571 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Premature Infant appearing as the primary indexed condition, and to 0 interventions.

NCT03345069 reports 1 study location spanning 1 distinct geographic area - top geographies include Ohio.

Frequently Asked Questions

What is clinical trial NCT03345069 about?

NCT03345069 is a clinical study titled "Cincinnati Infant Neurodevelopment Early Prediction Study (CINEPS)". The Early Prediction Study is a longitudinal population-based cohort study for very preterm infants ≤32 weeks gestational age. Preterm infants recruited from three greater Cincinnati and two Dayton area neonatal intensive care units (NICUs) will undergo advanced MRIs at 41 weeks postmenstrual age an...

What is the current status of trial NCT03345069?

This trial is currently active not recruiting. The enrollment target is 393 participants. The study started on 2016-09-16. Estimated completion is 2027-11.

What conditions does trial NCT03345069 study?

This clinical trial studies the following conditions: Premature Infant.

Who is sponsoring clinical trial NCT03345069?

This trial is sponsored by Children's Hospital Medical Center, Cincinnati, which has 571 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT03345069 being conducted?

This trial has 1 study location across Ohio. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Premature Infant

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.